84 related articles for article (PubMed ID: 21685933)
1. Disruption of Tacc3 function leads to in vivo tumor regression.
Yao R; Natsume Y; Saiki Y; Shioya H; Takeuchi K; Yamori T; Toki H; Aoki I; Saga T; Noda T
Oncogene; 2012 Jan; 31(2):135-48. PubMed ID: 21685933
[TBL] [Abstract][Full Text] [Related]
2. TACC3 depletion sensitizes to paclitaxel-induced cell death and overrides p21WAF-mediated cell cycle arrest.
Schneider L; Essmann F; Kletke A; Rio P; Hanenberg H; Schulze-Osthoff K; Nürnberg B; Piekorz RP
Oncogene; 2008 Jan; 27(1):116-25. PubMed ID: 17599038
[TBL] [Abstract][Full Text] [Related]
3. Control of Atm-/- thymic lymphoma cell proliferation in vitro and in vivo by dexamethasone.
Kuang X; Yan M; Liu N; Scofield VL; Qiang W; Cahill J; Lynn WS; Wong PK
Cancer Chemother Pharmacol; 2005 Mar; 55(3):203-12. PubMed ID: 15570424
[TBL] [Abstract][Full Text] [Related]
4. A small compound targeting TACC3 revealed its different spatiotemporal contributions for spindle assembly in cancer cells.
Yao R; Kondoh Y; Natsume Y; Yamanaka H; Inoue M; Toki H; Takagi R; Shimizu T; Yamori T; Osada H; Noda T
Oncogene; 2014 Aug; 33(33):4242-52. PubMed ID: 24077290
[TBL] [Abstract][Full Text] [Related]
5. Localization of human TACC3 to mitotic spindles is mediated by phosphorylation on Ser558 by Aurora A: a novel pharmacodynamic method for measuring Aurora A activity.
LeRoy PJ; Hunter JJ; Hoar KM; Burke KE; Shinde V; Ruan J; Bowman D; Galvin K; Ecsedy JA
Cancer Res; 2007 Jun; 67(11):5362-70. PubMed ID: 17545617
[TBL] [Abstract][Full Text] [Related]
6. TACC3 is required for the proper mitosis of sclerotome mesenchymal cells during formation of the axial skeleton.
Yao R; Natsume Y; Noda T
Cancer Sci; 2007 Apr; 98(4):555-62. PubMed ID: 17359303
[TBL] [Abstract][Full Text] [Related]
7. The centrosomal adaptor TACC3 and the microtubule polymerase chTOG interact via defined C-terminal subdomains in an Aurora-A kinase-independent manner.
Thakur HC; Singh M; Nagel-Steger L; Kremer J; Prumbaum D; Fansa EK; Ezzahoini H; Nouri K; Gremer L; Abts A; Schmitt L; Raunser S; Ahmadian MR; Piekorz RP
J Biol Chem; 2014 Jan; 289(1):74-88. PubMed ID: 24273164
[TBL] [Abstract][Full Text] [Related]
8. The centrosomal protein TACC3 controls paclitaxel sensitivity by modulating a premature senescence program.
Schmidt S; Schneider L; Essmann F; Cirstea IC; Kuck F; Kletke A; Jänicke RU; Wiek C; Hanenberg H; Ahmadian MR; Schulze-Osthoff K; Nürnberg B; Piekorz RP
Oncogene; 2010 Nov; 29(46):6184-92. PubMed ID: 20729911
[TBL] [Abstract][Full Text] [Related]
9. T lymphoblastic leukaemia with an unusual Burkitt lymphoma morphology--a case report.
Pazur M; Jelić-Puskarić B; Planinc-Peraica A; Vrhovac R; Kardum-Skelin I; Jaksić B
Coll Antropol; 2010 Jun; 34(2):675-8. PubMed ID: 20698152
[TBL] [Abstract][Full Text] [Related]
10. V(D)J recombination is not required for the development of lymphoma in p53-deficient mice.
Nacht M; Jacks T
Cell Growth Differ; 1998 Feb; 9(2):131-8. PubMed ID: 9486849
[TBL] [Abstract][Full Text] [Related]
11. Coordination of adjacent domains mediates TACC3-ch-TOG-clathrin assembly and mitotic spindle binding.
Hood FE; Williams SJ; Burgess SG; Richards MW; Roth D; Straube A; Pfuhl M; Bayliss R; Royle SJ
J Cell Biol; 2013 Aug; 202(3):463-78. PubMed ID: 23918938
[TBL] [Abstract][Full Text] [Related]
12. Normal lymphocyte development and thymic lymphoma formation in Brca1 exon-11-deficient mice.
Bachelier R; Xu X; Wang X; Li W; Naramura M; Gu H; Deng CX
Oncogene; 2003 Jan; 22(4):528-37. PubMed ID: 12555066
[TBL] [Abstract][Full Text] [Related]
13. Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes.
Rapoport AP; Simons-Evelyn M; Chen T; Sidell R; Luhowskyj S; Rosell K; Obrig T; Hicks D; Hinkle PM; Nahm M; Insel RA; Abboud CN
Blood Cells Mol Dis; 2001; 27(3):610-24. PubMed ID: 11482875
[TBL] [Abstract][Full Text] [Related]
14. Expression of transforming acidic coiled-coil containing protein 3 is a novel independent prognostic marker in non-small cell lung cancer.
Jung CK; Jung JH; Park GS; Lee A; Kang CS; Lee KY
Pathol Int; 2006 Sep; 56(9):503-9. PubMed ID: 16930330
[TBL] [Abstract][Full Text] [Related]
15. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
[TBL] [Abstract][Full Text] [Related]
16. Highly aggressive lymphomas in adults.
Sweetenham JW
Hematol Oncol Clin North Am; 2008 Oct; 22(5):965-78, ix. PubMed ID: 18954746
[TBL] [Abstract][Full Text] [Related]
17. Stromelysin-1 (MMP-3) is inducible in T lymphoma cells and accelerates the growth of lymphoid tumors in vivo.
Van Themsche C; Potworowski EF; St-Pierre Y
Biochem Biophys Res Commun; 2004 Mar; 315(4):884-91. PubMed ID: 14985095
[TBL] [Abstract][Full Text] [Related]
18. Anticancer effects on TACC3 by treatment of paclitaxel in HPV-18 positive cervical carcinoma cells.
Yim EK; Tong SY; Ho EM; Bae JH; Um SJ; Park JS
Oncol Rep; 2009 Feb; 21(2):549-57. PubMed ID: 19148534
[TBL] [Abstract][Full Text] [Related]
19. TLX1-induced T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Ferrando AA
Clin Cancer Res; 2011 Oct; 17(20):6381-6. PubMed ID: 21705452
[TBL] [Abstract][Full Text] [Related]
20. Mitotic drug targets and the development of novel anti-mitotic anticancer drugs.
Schmidt M; Bastians H
Drug Resist Updat; 2007; 10(4-5):162-81. PubMed ID: 17669681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
